Sintx Technologies (SINT) Liabilities from Discontinued Operations (2017)
Sintx Technologies' quarterly Liabilities from Discontinued Operations came in at 2356000.0 in Q4 2017.
Sintx Technologies has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 2356000.0 in Q4 2017.
- For the quarter ending Q4 2017, Liabilities from Discontinued Operations changed N/A year-over-year to 2356000.0; the trailing twelve-month figure through Dec 2017 stood at 2356000.0 (changed N/A YoY), and the FY2017 full-year result was 2356000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2017 stood at 2356000.0.
- The five-year high for Liabilities from Discontinued Operations was 2356000.0 in Q4 2017, with the low at 2356000.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 2.36 Mn |
| Dec 31, 2017 | 2.36 Mn |